-
Featured
Coronary Artery Disease: Pathways and Subtypes
Precision medicine can help answer whether or not current heart disease treatment paradigms optimally address genetic heterogeneity.
-
Featured
Hope for High-risk Coronary Artery Patients
Many patients with complex CAD are high-risk and ineligible for surgical treatment. Alternative and advanced interventions at Mass General are proving to be effective.
-
Featured
Coronary Artery Disease - Reporting & Data System (CAD-RADS)
Massachusetts General Hospital clinicians discuss a male age 55 that presents with left sided chest pain and has a history of hypertension and hyperlipidemia.
-
Polygenic Scores for Cardiometabolic Diseases Correlate Strongly Across Siblings
In a study with substantial implications for genetic counseling, Amit V. Khera, MD, MSc, of the Center for Genomic Medicine, and colleagues found that when individuals with high polygenic scores were defined as those in the top 20% of the distribution, about 45% of their siblings met the same threshold.
-
X Chromosome Locus Is Associated with Lower Atherogenic Lipids, Favorable Cardiometabolic Traits
Variants in chromosome Xq23 are linked to reduced total cholesterol, LDL cholesterol and triglycerides, and reduced risk of coronary heart disease and type 2 diabetes, according to whole-genome data analyzed by Pradeep Natarajan, MD, MMSc, and an international team of colleagues.
-
Discordance Across High-Sensitivity Troponin Assays Can Affect Management of Suspected ACS
Júlia Karády, MD, and Udo Hoffman, MD, MPH, of the Cardiovascular Imaging Research Center, observed marked discordance between high-sensitivity cardiac troponin assays that would lead to different management of patients with suspected acute coronary syndrome who had an inconclusive initial evaluation.
Coronary Artery Disease Contributors
-
Douglas E. Drachman, MD
Director, Cardiovascular Fellowship Program, Director, Interventional Cardiology Fellowship Program
Recent Article
ACC 2019: A Media Roundup
-
Farouc A. Jaffer, MD, PhD
Director, Coronary Intervention, Massachusetts General Hospital, Director, MGH Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI) program, Associate Physician, MGH Cardiology, Department of Medicine
Recent Article
Reducing Post-Thrombotic Syndrome Through Reperfusion After DVT May Be Time-Sensitive
-
Hanna K. Gaggin, MD, MPH
Assistant Physician, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Review: Predicting Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction
-
James Louis Januzzi, MD
Hutter Family Professor of Medicine, Director, Dennis and Marilyn Barry Fellowship in Cardiology Research
Recent Article
Reverse Cardiac Remodeling May Underlie Benefit of Sacubitril/Valsartan in HFrEF
-
Malissa J. Wood, MD
Co-Director, Corrigan Women's Heart Health Program
Recent Article
Review: Does Patient–Physician Gender Concordance Influence Patient Perceptions or Outcomes?
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.Resource links
